Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
doi: 10.1016/j.soard.2019.06.022 16 JerlhagE.EgeciogluE.DicksonS
Eye on the FDA ONE PIVOTAL TRIAL FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research Vinay Prasad made official Wednesday what Makary told STAT in December: that the agencys new default position is that drugmakers need only a single trial in most instances to win marketing approval
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
He L, He T, Farrar S, Ji L, Liu T, Ma X
US$ 24.63
US$ 24.30
US$ 27.72
US$ 27.94
US$ 26.73
US$ 22.55
US$ 20.26
US$ 25.40
